evaluate the pharmaceuticals and biotechnology company pfizer on top glp-1's gains another obesity asset with $2bn deal for YaoPharma's GLP-1RA Pfizer's Experimental Weight Loss Drug

PubMed laboratory research record [PMID: 39965963] PubMed record related to this compound for laboratory literature review

It stimulates glycosaminoglycan synthesis the production of hyaluronic acid and dermatan sulfate that hydrate skin and provide the scaffolding for collagen deposition

Oral decongestants containing pseudoephedrine or phenylephrine can cause severe hypertension when taken with propranolol due to unopposed alpha-adrenergic stimulation

Understanding why requires looking beyond hormone panels

However, overexposure to sunlight can cause your skin to darken or become more tanned again

If youve been following the rise of GLP-1s as obesity drugs, this is a story worth watching